Cart
sales@molnova.com
δ-Valerolactone
CAS No. 542-28-9
δ-Valerolactone( Tetrahydro-2H-pyran-2-one | δ-Valeryllactone | 2-Oxotetrahydropyran )
Catalog No. M19622 CAS No. 542-28-9
δ-Valerolactone is a compound commonly used to synthesize copolyesters by means of lipase-catalyzed ring-opening polymerization.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | 27 | In Stock |
|
Biological Information
-
Product Nameδ-Valerolactone
-
NoteResearch use only, not for human use.
-
Brief Descriptionδ-Valerolactone is a compound commonly used to synthesize copolyesters by means of lipase-catalyzed ring-opening polymerization.
-
Descriptionδ-Valerolactone is a compound commonly used to synthesize copolyesters by means of lipase-catalyzed ring-opening polymerization.
-
In Vitro——
-
In Vivo——
-
SynonymsTetrahydro-2H-pyran-2-one | δ-Valeryllactone | 2-Oxotetrahydropyran
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number542-28-9
-
Formula Weight100.12
-
Molecular FormulaC5H8O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESO=C1CCCCO1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Houk K. Jabbari A. Hall H. & Alemán C. (2008). Why δ-Valerolactone Polymerizes and γ-Butyrolactone Does Not. The Journal Of Organic Chemistry 73(7) 2674-2678. doi: 10.1021/jo702567v
molnova catalog
related products
-
12-oxo-N-[1-(propan-...
12-oxo-N-[1-(propan-2-yl)piperidin-4-yl]-6H,7H,8H,9H,10H,12H-azepino[2,1-b]quinazoline-3-carboxamide is a compound used as a molecular building block.
-
NSC87877
NSC-87877 is a cell-permeable inhibitor of both SHP-1 and SHP-2 with IC50 values of 355 and 318 nM respectively.
-
Nurr1 agonist 2
Nurr1 agonist 2 is a Nurr1 agonist with an EC50 value of 0.07 μM. Nurr1 agonist 2 increases the mRNA expression of the Nurr1-regulated genes tyrosine hydroxylase (TH) and vesicular amino acid transporter 2 (VMAT2).
